Cdkn1A is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
CDKN1A (p21) is a cyclin-dependent kinase inhibitor that arrests the cell cycle. It is a key mediator of p53-dependent cell cycle arrest. In neurons, p21 is involved in neuronal differentiation, survival, and DNA damage responses.
CDKN1A is involved in various cellular processes relevant to neurodegenerative disease research.
CDKN1A (p21) is a cyclin-dependent kinase inhibitor that arrests the cell cycle. It is a key mediator of p53-dependent cell cycle arrest. In neurons, p21 is involved in neuronal differentiation, survival, and DNA damage responses.
Ubiquitously expressed, induced by p53.
The study of Cdkn1A has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.